Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

To the Editor: As of 2019 National Cancer Institute data show that melanoma is the fifth most common cancer in the United States.1 There has been a recent push to include the histopathologic subtype of nodular melanoma as an independent prognostic classifier due to the identification of associated aggressive histopathologic characteristics and shorter recurrence-free times.2,3